Through the combination of this molecule and synthetic non-psychoactive cannabinoids they are developing a first-in-class therapy. ReFormation … Read More
The post Resinco Capital Partners Announces Remaining Acquisition of ReFormation Pharmaceuticals Corp appeared first on Dagga Magazine.